Adlai Nortye Group (ANL) vs Ardelyx (ARDX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Adlai Nortye Group (ANL) has outperformed Ardelyx (ARDX) over the past year, gaining 796.5% versus a loss of 35.4%. Adlai Nortye Group is the larger company by market cap ($1.00 billion vs $840.4 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ANL | ARDX |
|---|---|---|
| Share price | $15.57 | $3.26 |
| Market cap | $1.00B | $840.40M |
| 1-day change | +0.39% | -0.46% |
| YTD return | +992.25% | -43.91% |
| 1-year return | +796.53% | -35.38% |
| 5-year return | — | +202.78% |
| Forward P/E | — | 11.21 |
| EPS (TTM) | $-0.66 | $-0.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $17.25 | $8.40 |
| 52-week low | $0.879 | $3.18 |
| Distance from 52-week high | -9.74% | -61.25% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +89.47% | +296.31% |
| Average volume | 187.30K | 4.17M |
| Shares outstanding | 58.73M | 258.19M |
| Employees | 109 | 489 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ANL has outperformed ARDX by 831.9 percentage points over the past year.
About Adlai Nortye Group
ANL stock →Adlai Nortye Group Ltd., a clinical-stage biopharmaceutical company, engages in the discovery and development of cancer therapies. The company's pipeline centers on RAS-targeting therapies and next-generation cancer immunotherapies.
Health Care · Biotechnology: Pharmaceutical Preparations · 109 employees
About Ardelyx
ARDX stock →Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
Health Care · Biotechnology: Pharmaceutical Preparations · 489 employees
ANL vs ARDX FAQ
Which is bigger, Adlai Nortye Group or Ardelyx?
Adlai Nortye Group (ANL) is larger, with a market capitalization of $1.00B compared with $840.40M for Ardelyx (ARDX).
Which stock has performed better over the past year, ANL or ARDX?
ANL returned +796.53% over the past 12 months, compared with -35.38% for ARDX (price return, excluding dividends). Past performance does not predict future results.
Are Adlai Nortye Group and Ardelyx in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.